Aligning Science Across Parkinson's Logo Text

Regulation of the proteasome 20S core particle by the Parkinsonism-associated Proteins FBXO7 and PI31

Output Details

FBXO7 and PI31 variants are linked to rare Parkinsonian syndromes, implicating their dysfunction in neurodegeneration. We define how both engage each other and regulate the proteasome 20S core particle (CP). In cells, each can associate independently with the proteasome, with multiple domains in FBXO7 contributing. Utilizing cryo-EM we visualized how FBXO7’s C-terminal domain engages multiple subunits within the CP interior, blocking the β5 peptidase activity. In contrast, we visualized PI31 engagement of all three catalytic sites within the 20S CP, revealing the previously unknown structural basis for β1 inhibition. Furthermore, we establish how disease-associated variants impact both FBXO7 and PI31 function, including disruption of proteasome inhibition and SKP1–FBXO7–PI31 complex assembly. These results establish an unexpected function for FBXO7, providing a mechanistic basis for investigation of its role in proteasome regulation in Parkinson’s disease.
Tags
  • Autosomal recessive PD
  • Original Research
  • Proteostasis
  • Structural biology

Meet the Authors

  • User avatar fallback logo

    Frank Adolf

    External Collaborator

  • User avatar fallback logo

    Ellen Goodall

    External Collaborator

  • User avatar fallback logo

    Ekampreet (Ekam) Singh

    External Collaborator

  • User avatar fallback logo

    Susanne von Gronau

    External Collaborator

  • User avatar fallback logo

    Erignacio Fermin Perez

    External Collaborator

  • User avatar fallback logo

    Darlene Fung

    External Collaborator

  • User avatar fallback logo

    Benedikt S. Müller

    External Collaborator

  • User avatar fallback logo

    Joao A. Paulo

    External Collaborator

  • User avatar fallback logo

    John Hanna,

    External Collaborator

  • J. Wade Harper

    Lead PI (Core Leadership): Team Harper

    Harvard University

  • Brenda Schulman, PhD

    Co-PI (Core Leadership): Team Harper

    Max Planck Institute of Biochemistry

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.